FindTrial
Sign In

Effect of Dexmedetomidine Combined with Remifentanil for Patients with Colonoscopy

Effect of Dexmedetomidine Combined with Remifentanil for Patients with Colonoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029105
Enrollment
Unknown
Registered
2020-01-13
Start date
2017-12-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless Colonoscopy

Interventions

Group I:DEX 0.2ug/kg
Group II:DEX 0.3ug/kg
Group III:DEX 0.4ug/kg

Sponsors

the Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I-II; 2. aged 45-64 years.

Exclusion criteria

Exclusion criteria: 1. with sinus bradycardia; 2. with atrioventricular block; 3. patient refusal.

Design outcomes

Primary

MeasureTime frame
Blood Pressure;Heart Rate;SpO2;Respiratory Rate;BIS;Satisfaction Degree;—

Secondary

MeasureTime frame
Operation Time;—

Countries

China

Contacts

Public ContactJia Li

the Fourth Hospital of Hebei Medical University

281575038@qq.com+86 13933089766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026